# FDA 483 - Aditya Bardia, M.D. - February 08, 2021

Source: https://www.globalkeysolutions.net/records/483/aditya-bardia-md/47fdf899-db2d-4ca9-bead-96d59ec78a77

> FDA 483 for Aditya Bardia, M.D. on February 08, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aditya Bardia, M.D.
- Inspection Date: 2021-02-08
- Product Type: drugs
- Office Name: Division of Northeast Imports 
- Summary: An FDA inspection of Aditya Bardia, M.D. in Boston, MA, a clinical investigator, revealed that an investigation was not conducted in accordance with the investigational plan. Specifically, subjects were not enrolled according to protocol criteria regarding prior chemotherapy, and required scans were taken outside of the specified timeframe. These findings indicate a significant deviation from the study protocol.

## Related Documents

- [483 - 2018-08-17](https://www.globalkeysolutions.net/records/483/aditya-bardia-md/220b0e7e-8eb5-4447-ab5d-bcecea4fea8e)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)

Company: https://www.globalkeysolutions.net/companies/aditya-bardia-md/e2d6eaff-4279-4e74-b614-0455933f7b91

Office: https://www.globalkeysolutions.net/offices/division-of-northeast-imports/b20599cf-9797-41fd-947f-6589ef596a94